<DOC>
	<DOC>NCT01310686</DOC>
	<brief_summary>To obtain a genotypic analysis of patients with chronic exudative age-related macular degeneration noted to have subretinal or intraretinal edema despite continuous monthly Anti-VEGF therapy.</brief_summary>
	<brief_title>Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Ability to provide written informed consent for participation in this study Subjects diagnoses of neovascular AMD who are on a monthly antiVEGF regimen (have had &gt;10 or more ranibizumab and/or bevacizumab injections within the last year) and who still have intraretinal or subretinal fluid as confirmed by the Investigator Subjects with a Pigment Epithelial Detachment Exclusively Subjects with Serous Pigment Epithelial Detachments Subjects with history of the following: idiopathic polypoidal choroidal vasculopathy pathologic degenerative myopia central serous chorioretinopathy familial drusen adult onset foveal pattern dystrophy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>wet AMD anti-VEGF</keyword>
	<keyword>Genetic analysis of patients with Wet AMD who have not responded fully to anti-VEGF treatments</keyword>
</DOC>